Advantame vs Sodium Aluminum Phosphate: which is worse?

What is Advantame?

Advantame is the newest FDA-approved synthetic sweetener, approved in 2014. Like neotame, it is a structural derivative of aspartame but with a vanillin-derived substituent. It is approximately 20,000 times sweeter than sucrose — the most potent sweetener currently approved for food use in the US.

What is Sodium Aluminum Phosphate?

Sodium aluminum phosphate (SALP) is a leavening acid and food additive used in baked goods, particularly self-rising flour and baking powder. It provides a slow, sustained leavening action during baking. SALP is also used as an emulsifying salt in processed cheese products.

Documented risks

Advantame: Advantame is the newest approved high-intensity sweetener with the least post-approval safety data. The FDA approval was based on extensive pre-market animal studies showing no significant toxicity, carcinogenicity, reproductive toxicity, or neurotoxicity at relevant doses. EFSA approved it for EU use in 2014, finding no safety concerns based on the submitted data. Like other synthetic sweeteners, advantame has not been studied for long-term effects in large human populations post-approval. The same gut microbiome and glucose tolerance concerns raised for other sweeteners (aspartame, sucralose, acesulfame K) have not been specifically studied for advantame, though the class-wide concerns are relevant. Given its 2014 approval date, independent long-term safety studies are still limited.

Sodium Aluminum Phosphate: The primary health concern with SALP is aluminum exposure. Dietary aluminum intake has been studied in relation to neurotoxicity, and there is ongoing scientific debate about whether chronic dietary aluminum exposure contributes to Alzheimer's disease risk. EFSA's 2008 review of dietary aluminum exposure concluded that the tolerable weekly intake (TWI) was being exceeded by some European populations based on total dietary aluminum sources, raising concern. A 2011 EFSA risk assessment noted that certain high-aluminum sources (including baked goods from SALP-containing leavening agents) contributed meaningfully to total dietary aluminum. The WHO has set a PTWI (provisional tolerable weekly intake) of 2 mg/kg body weight/week for total aluminum. However, the causal link between dietary aluminum from food-grade SALP and Alzheimer's disease has not been definitively established in human studies.